✦ LIBER ✦

242 EFFECT OF HIGH-DOSE RIBAVIRIN (RBV), ALINIA (NITAZOXANIDE) AND PEGYLATED INTERFERON (PEGIFN) ALFA-2A IN ATTAINING SUSTAINED VIROLOGIC RESPONSE (SVR) IN TREATMENT OF CHRONIC HEPATITIS C

✍ Scribed by P. Basu; K. Rayapudi; N.J. Shah; T. Pacana; N. Krishnaswamy; R. Brown Jr.

Book ID: 117378328
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 73 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(10)60244-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S1272 Effect of High-Dose Ribavirin (RBV

S1272 Effect of High-Dose Ribavirin (RBV), Alinia (Nitazoxanide) and Pegylated Interferon (pegIFN) Alfa-2a in Attaining Sustained Virologic Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-C Trial) in Naïve Genotype 1 Patients

✍ P. Patrick Basu; Krishna Rayapudi; Tommy Pacana; Niraj James Shah; Nithya Krishn 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 79 KB

OL-002 Effect of high-dose ribavirin (RB

OL-002 Effect of high-dose ribavirin (RBV), Alinia (Nitazoxanide) and pegylated interferon (PegIFN) alfa-2a in attaining sustained virologic response (SVR) in treatment of chronic hepatitis C (ERAIS-C Trial) in naive genotype 1 patients

✍ P.P. Basu; K. Rayapudi; T. Pacana; N.J. Shah; N. Krishnaswamy; H. Hampole; C. Ta 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 224 KB

Association of host pharmacodynamic effe

Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C

✍ Raymond T. Chung; Fred F. Poordad; Tarek Hassanein; Xiaolei Zhou; Ellen Lentz; A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 773 KB

Patients receiving therapy for chronic hepatitis C virus (HCV) infection frequently experience cytopenias and weight loss. We retrospectively assessed the pharmacodynamic effects of pegylated interferon (PEG-IFN) alfa-2a and ribavirin by evaluating the relationship between changes in hematologic par

1352 IL28B-CC GENOTYPE-RELATED GENE EXPR

1352 IL28B-CC GENOTYPE-RELATED GENE EXPRESSION DURING TREATMENT OF CHRONIC HEPATITIS C (CH-C) WITH PEGYLATED INTERFERON-ALFA (PEG-IFN) AND RIBAVIRIN (RBV): POTENTIAL MECHANISMS FOR SUSTAINED VIROLOGIC RESPONSE (SVR)

✍ Younossi, Z.M.; Estep, J.M.; Birerdinc, A.; Stepanova, M.; Baranova, A.; Younoss 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 34 KB

766 A PANEL OF GENE EXPRESSION BIOMARKER

766 A PANEL OF GENE EXPRESSION BIOMARKERS PREDICTING SUSTAINED VIROLOGIC RESPONSE (SVR) IN CHRONIC HEPATITIS C PATIENTS (CH-C) TREATED WITH PEGYLATED INTERFERON ALPHA AND RIBAVIRIN

✍ Z.M. Younossi; A. Baranova; M. Stepanova; A. Afendy; A. Wheeler; N. Hossain; A. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

475 Sustained virological response (SVR)

475 Sustained virological response (SVR) to peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) vs induction therapy with interferon alfa-2A (Roferon-A) plus RBV and AMA in IFN/RBV non responders (NR) with chronic hepatitis C (CHC)

✍ S. Fargion; M. Borzio; A. Maraschi; A. Cargnel 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 61 KB